Olanzapine in the Treatment of Patients With Anorexia Nervosa
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy of an anti-psychotic medication,
Olanzapine, in achieving desired weight gain in patients identified as having Anorexia
Nervosa, either restricting or binge/purge subtype. The study will also evaluate the possible
beneficial effects of Olanzapine in reducing the severity of the obsessive and/or anxiety
symptoms associated with this disorder.